Jump to content

N-Phenylacetyl-L-prolylglycine ethyl ester: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

22 December 2024

26 November 2024

29 October 2024

19 October 2024

17 October 2024

13 October 2024

8 October 2024

11 August 2024

2 April 2024

21 March 2024

16 February 2024

16 January 2024

22 October 2023

19 September 2023

10 August 2023

21 July 2023

8 July 2023

  • curprev 06:4106:41, 8 July 2023 Irruptive Creditor talk contribs m 11,777 bytes −38 The term drug in U.S. law includes any article intended to affect the structure or function of the body. Peak Nootropics products, if marketed as cognitive enhancers, meet the statutory standard. Calling Omberacetam not a drug is a dubious claim at best. undo Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit

27 April 2023

7 April 2023

6 March 2023

5 March 2023

4 March 2023

15 February 2023

3 February 2023

28 January 2023

9 January 2023

29 November 2022

14 November 2022

22 October 2022

15 September 2022

30 August 2022

31 July 2022

9 July 2022

8 July 2022

10 June 2022

3 March 2022

15 February 2022

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)